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Stem cell division can result in two sibling cells
exhibiting differential mitogenic and self-renewing
potential. Here, we present evidence that the dual-
specificity kinase Dyrk1A is part of a molecular path-
way involved in the regulation of biased epidermal
growth factor receptor (EGFR) signaling in the
progeny of dividing neural stem cells (NSC) of the
adult subependymal zone (SEZ). We show that
EGFR asymmetry requires regulated sorting and
that a normal Dyrk1a dosage is required to sustain
EGFR in the two daughters of a symmetrically
dividingprogenitor. Dyrk1A is symmetrically or asym-
metrically distributed during mitosis, and biochem-
ical analyses indicate that it prevents endocytosis-
mediated degradation of EGFR by a mechanism
that requires phosphorylation of the EGFR signaling
modulator Sprouty2. Finally, Dyrk1a heterozygous
NSCsexhibit defects in self-renewal, EGF-dependent
cell-fatedecisions, and long-termpersistence in vivo,
suggesting that symmetrical divisions play a role in
the maintenance of the SEZ reservoir.
INTRODUCTION
Asymmetric division allows stem cell pools to simultaneously
self-renew and generate committed progeny, but it is becoming
increasingly clear that stem cells modulate their numbers by
switching between symmetrical and asymmetrical division
modes (Morrison and Kimble, 2006). The subependymal zone
(SEZ), adjacent to the lateral ventricles of the murine adult brain,
is a very active germinal niche in which continual production ofCelldifferentiated progeny is supported by a relatively quiescent
population of astroglia/radial glia-like neural stem cells (NSC),
named B cells. The progeny of glial fibrillary acidic protein
(GFAP)-expressing B cells are transit-amplifying progenitor
(TAP) cells, which rapidly divide and give rise to olfactory bulb
(OB) local-circuitry neurons and to callosal oligodendrocytes
(Zhao et al., 2008). In response to mitogenic stimuli, isolated
SEZ cells produce clonal neurospheres, and long-term expan-
sion of these cultures is considered an indication that symmet-
rical self-renewing divisions take place in vitro (Morshead and
van der Kooy, 2004). Modes of division by adult NSCs in the
SEZ, however, have not been extensively investigated. Hori-
zontal and vertical cleavage planes with respect to the ventricle
have been observed in dividing progenitors of the intact and
ischemic SEZ, but whether symmetrical division modes
occurred in B or TAP cells could not be determined (Zhang
et al., 2004). Nevertheless, B cells exhibit properties of apico-
basal polarity (Mirzadeh et al., 2008) and increase their numbers
under certain conditions, suggesting that NSCs can divide
symmetrically (Doetsch et al., 1999; Zhang et al., 2004).
Stem cell expansion in response to increased cellular demand
suggests that niche signals modulate division mode, possibly
acting on cell polarity factors and partitioning of fate determi-
nants; in turn, differentially segregated molecules may function
by altering gene expression and/or by modifying responsiveness
to external cues in daughter cells. Molecules that regulate
asymmetrical division in Drosophila neurogenesis are conserved
in vertebrates; some of them exhibit polarized distribution in
mammalian neural progenitor cells (NPC) and are involved in
cell-fate decisions (Knoblich, 2008; Zhong and Chia, 2008).
However, very little is known about the molecular players
involved in determining biased signaling in adult mammalian
stem cells. Recent studies have shown that epidermal growth
factor receptor (EGFR) distribution varies between the siblings
of fetal and adult NPCs and that inheritance of unequal receptorStem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier Inc. 367
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dreu-Agullo´ et al., 2009). Unequal EGFR distribution is achieved
by differential Notch-dependent transcription (Andreu-Agullo´
et al., 2009), but other possibilities, such as regulation of receptor
trafficking, have not been evaluated.
Dyrk1A, a member of the dual-specificity tyrosine-phosphory-
lated and regulated kinase family, is expressed in developing
and mature nervous systems (Martı´ et al., 2003; Ha¨mmerle
et al., 2008) and plays a role in brain growth. DYRK1A maps to
the Down syndrome critical region of human chromosome 21,
and its overexpression has been associated with some of the
neurological defects observed in affected individuals (Park
et al., 2009). DYRK1A dosage sensitivity is further highlighted
by the fact that truncating mutations in hemizygosis result
in microcephaly (Møller et al., 2008). Likewise, Dyrk1a loss-of-
function mutations in Drosophila (minibrain) and mice result in
defective neurogenesis (Tejedor et al., 1995; Fotaki et al.,
2002). Dyrk1A phosphorylates substrates as diverse as microtu-
bule-associated protein tau, caspase-9, Sprouty2 (Spry2), intra-
cellular domain of Notch, or Shh effector Gli1, suggesting a
possible role as signaling integrator (Galcera´n et al., 2003;
Aranda et al., 2008; Laguna et al., 2008; Fernandez-Martinez
et al., 2009). Notably,Dyrk1amRNA exhibits a polarized distribu-
tion in dividing neuroepithelial cells of the chick and mouse
neural tubes (Ha¨mmerle et al., 2002; 2008). Together, these
data suggest a conserved essential role of Dyrk1A in neural
development and, possibly, in asymmetric division.
We show here that Dyrk1A is expressed by B and TAP cells of
the SEZ and that a reduction in Dyrk1A levels negatively impacts
on the persistence of NSCs in this niche, a defect that correlates
with impaired self-renewal of Dyrk1a heterozygous cells in vitro
in response to EGF. Dyrk1A distributes both symmetrically and
asymmetrically during mitosis of neurosphere-initiating cells,
and EGFR levels and distribution in daughter cells depend on
the amount of inherited Dyrk1A. Our data support a role for
Dyrk1A as an inhibitor of EGFR degradation acting in the same
pathway as the EGF-signaling regulator Spry2. Finally, we
demonstrate that cell-fate decisions in response to EGF are
altered in Dyrk1a heterozygous mice. Altogether, our data indi-
cate that the regulation of EGF biased signaling by Dyrk1A
controls NSC maintenance and mobilization in the mammalian
SEZ.
RESULTS
Dyrk1A Is Expressed by NPCs of the Adult SEZ
and Regulates NSC Longevity
Dyrk1A distribution in the murine adult brain had been previously
analyzed (Martı´ et al., 2003), but expression in neurogenic
regions was not reported. We detected Dyrk1A in SEZ and neu-
rosphere homogenates by immunoblot and in all cells of the
ependymal layer and in subependymal GFAP+ cells and
Mash1+ TAP cells, but not in bIII-tubulin+ neuroblasts, by immu-
nohistochemistry (Figures 1A and 1B and Figures S1A–S1F).
Dyrk1A was observed in GFAP+ cells positive for the stem cell
marker Sox2 and in cells that retained bromo-deoxyuridine for
one month (BrdU label-retaining cells, BrdU-LRCs) (Figures 1C
and 1D). ‘‘Activated’’ proliferative GFAP+ B cells express EGFR
(Doetsch et al., 2002; Pastrana et al., 2009), and virtually all368 Cell Stem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier InGFAP+/EGFR+ cells (29 ± 2% of all GFAP+ cells, n = 3) were
positive for Dyrk1A (Figure 1E). We could also detect Dyrk1A in
dividing GFAP+ cells; notably, in some late mitoses, one
daughter had detectable levels of Dyrk1A, whereas the other
one hardly displayed any staining (Figures 1F and 1G and Movie
S1), suggesting unequal Dyrk1A inheritance in NSC daughters
(see also Figures S1G and S1H and Movie S2).
We next explored potential roles of Dyrk1A in the SEZ of
3-month-old (3-m) Dyrk1a+/ mice with reduced levels of the
kinase (Figures 1A and 1B). These mice exhibit reduced brain
size (Fotaki et al., 2002) and SEZ volumes (Dyrk1a+/+: 0.037 ±
0.001 mm3; Dyrk1a+/: 0.025 ± 0.002 mm3; n = 5, p < 0.05;
32% reduction) and reduced densities of GFAP+ and GFAP+/
Sox2+ cells, but not of Mash1+ TAP cells or bIII-tubulin+ neuro-
blasts (Figures 2A and 2B). Likewise, the proliferative activity of
GFAP+ cells, but not of Mash1+ cells or neuroblasts, was
reduced in Dyrk1a mutants, suggesting specific effects of the
mutation in B cells (Figures 2A and 2B). The lack of differences
in BrdU/Ki67 ratio between genotypes (Dyrk1a+/+: 76.7 ± 7.4%;
Dyrk1a+/: 75.6 ± 1.5%; n = 3; Figure 2A) suggested that Dyrk1a
heterozygosity does not result in an overall alteration of cell-
cycle parameters in the SEZ but in fewer proliferating B cells.
Consistently, primary neurosphere yield was reduced in 3-m
Dyrk1a+/ mice (Figures 2C and 2D; a small non-statistically
significant reduction was observed at 2-m). Moreover, the
difference in primary neurospheres between Dyrk1a+/+ and
Dyrk1a+/ mice steadily increased with age (Figure 2D) without
further reductions in SEZ volume (Dyrk1a+/+: 0.042 ± 0.008 mm3;
Dyrk1a+/: 0.027 ± 0.004 mm3; n = 5 at 12-m, p < 0.05; 35%
reduction). In contrast, no differences were detected in primary
sphere yields from the SEZ of 4 day pups (Dyrk1a+/+: 1280 ± 160;
Dyrk1a+/: 1340 ± 105; n = 4), indicating that normal levels of
Dyrk1A are not required for the generation of adult progenitors
but for their life-long maintenance.
Reduced Expression of Dyrk1A Impairs EGF-Induced
Self-Renewal In Vitro
The specific decrease in neurosphere recovery from Dyrk1a+/
SEZs suggested that normal levels of Dyrk1A are necessary for
self-renewal. Accordingly, Dyrk1a+/ primary spheres grown in
EGF + basic fibroblast growth factor (FGF) formed fewer
secondary clones than wild-types (Figure 2E). Despite the differ-
ence in self-renewal, wild-type and Dyrk1a+/ cells did not differ
in proliferation, cytokinesis, and apoptosis rates during the first
passages, although defects in proliferation and progressive
exhaustion were noticeable in Dyrk1a+/ cultures after passage
5 (Figures S2A–S2F). Therefore, a reduction in the frequency of
symmetrical divisions in neurosphere-forming cells appears to
be the primary phenotype of Dyrk1a haploinsufficiency.
Acute reduction of Dyrk1a expression in wild-type cells by
siRNA also resulted in decreased neurosphere numbers, which
could be partially reverted by retroviral delivery of a siRNA-resis-
tant DYRK1A cDNA (Figure S2G). In contrast, overexpression of
Dyrk1A did not affect neurosphere formation, as wild-type cells
infected with a DYRK1A-containing retrovirus or cells from the
SEZs of transgenic mice overexpressing Dyrk1a (Altafaj et al.,
2001) formed the same number of neurospheres as their corre-
sponding control cells (Figures S2G and S2H). Moreover, cocul-
ture experiments using transwell inserts with semipermeablec.
Figure 1. Expression of Dyrk1a in the Adult SEZ
Dyrk1A and b-actin in SEZ (A) and neurosphere (B) homogenates from wild-type (WT, +/+) and Dyrk1a heterozygous (+/) mice by immunoblotting. (C) GFAP,
Sox2, and Dyrk1A immunodetections. White arrows point at triple-positive cells. (D) Dyrk1A in BrdU-LRCs. (E) EGFR, GFAP, and Dyrk1A immunodetections.
White arrows point at triple-positive cells. (F) Dividing GFAP+ cell with membrane labeling for b-catenin and homogenous cytoplasmic staining for Dyrk1A. White
arrows point at GFAP+ processes. (G) Recently divided cells (white arrows) stained for GFAP, Dyrk1A, and b-catenin. Sytox Green labels nuclei. Bottom rows
show higher magnification of cells in the white square. See rotations of the stacked confocal planes in Movie S1. Scale bars in (C) and (E), 20 mm; (D), 10 mm.
(F) and (G): upper panels, 20 mm; lower panels, 10 mm.
See also Figure S1 and Movie S2.
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number of neurospheres formed by wild-type cells (Figure S2I),
suggesting that Dyrk1A acts cell-autonomously to regulate
self-renewal.
Next,Dyrk1a+/ andwild-type dissociated SEZswere cultured
in medium with either EGF or FGF, and primary neurospheres
formed under each condition were dissociated and plated
separately in EGF or FGF. Dyrk1a+/ neurospheres grown in
EGF yielded fewer secondary clones in either EGF or FGF than
their wild-type counterparts. In contrast, secondary sphere
formation did not differ between genotypes when cells hadCellbeen grown in FGF (Figure 2F), indicating that normal Dyrk1A
levels are specifically needed for EGF-induced symmetrical
divisions.
Dyrk1A Protein Is Segregated during NSC Division
and Regulates EGFR Distribution in Daughters
Dividing adult NSCs generate two daughters with asymmetric
distribution of EGFR (EGFRA; one cell with high and one cell
with low EGFR levels) or two siblings with equal, symmetric,
levels of EGFR (EGFRS) (Andreu-Agullo´ et al., 2009). Immunocy-
tochemistry in cell pairs showed that EGFR always colocalizedStem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier Inc. 369
Figure 2. Dyrk1A Regulates Self-Renewal
(A) Immunofluorescence for GFAP and BrdU (GFAP and Sox2 in the inset), Mash1 and Ki67, bIII-tubulin, and Ki67 and BrdU in BrdU-injected WT and
Dyrk1a+/ mice. Topro-3 labels nuclei. Dashed white lines indicate the limits of the lateral ventricle (V).
(B) Density and proliferative activity of GFAP+ B cells, Mash1+ TAP cells, and bIII-tubulin neuroblasts.
(C) Passage (P) 1 secondary neurospheres.
(D) Primary sphere yields from 3-, 8-, and 12-m mice in EGF+FGF. Percent reductions in Dyrk1a+/ versus Dyrk1a+/+ cultures are indicated.
(E) Secondary spheres formed in WT and Dyrk1a+/ cultures at P1 and P3.
(F) Secondary spheres formed in the presence of EGF or FGF by cells dissociated from primary neurospheres that had been previously grown in either EGF or
FGF. Scale bars in (A), 20 mm; insets, 10 mm.
See also Figure S2.
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(aPKC) l (Figure S3A). Moreover, unequal inheritance of EGFR
led to a differential capacity for neurosphere formation, as cells
with higher EGFR levels (sorted by FACS following incubation
with Alexa 488-conjugated EGF) formed 2-fold more neuro-
spheres than the population with low EGFR levels (Figure S3B).
Dyrk1A protein was also asymmetrically or symmetrically
distributed in daughters of a dividing neurosphere-initiating cell
and always detected in cells with high EGFR levels (Figure 3A).
Asymmetric segregation of Dyrk1A could not be observed until
telophase or cytokinesis, suggesting that Dyrk1A is unlikely to
act as an early polarity determinant, but its asymmetric segrega-370 Cell Stem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier Intion appeared to precede that of EGFR (Figure 3B). To investi-
gate whether asymmetrical distribution of Dyrk1A could be
the result of an active partitioning of Dyrk1A in the dividing cell,
we treated dissociated neurosphere cells with latrunculin A,
a drug that disrupts the actin meshwork, preventing uneven
distribution of asymmetric fate determinants (Sun et al., 2005).
Treated cells exhibited a 60% reduction in Dyrk1A asymmetry
(untreated, 32.2 ± 3.0%; treated, 11.7 ± 2.0%, n = 3, p < 0.05),
an indication that Dyrk1A unequal distribution may depend on
the actin cytoskeleton.
To analyze whether Dyrk1A haploinsufficiency affects EGFR
distribution, we compared the frequency of EGFRA and EGFRSc.
Figure 3. Mitotic EGFR and Dyrk1A Asym-
metry
Dyrk1A and EGFR in cell pairs (A) and in late
mitoses (B), showing symmetric and asymmetric
codistribution. DAPI labels nuclei. (C) EGFR and
NICD in WT and Dyrk1a+/ cell pairs. (D) Propor-
tion of cell pairs with asymmetrical distribution of
EGFR or NICD in WT and Dyrk1a+/ cells cultured
in EGF or FGF. (E) Proportion of cell pairs with
asymmetrical distribution of EGFR (EGFRA) in WT
and Dyrk1a+/ cells, either untreated () or treated
(+) with latrunculin A. Scale bars in (A)–(C), 10 mm.
See also Figure S3.
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in the relative proportion of EGFRA cell pairs inDyrk1a+/ cultures
(Figures 3C and 3D). This increase occurred at the expense of
EGFRS doublets, since the proportion of cell pairs in which bothCell Stem Cell 7, 367–379, Scells were EGFR-low was not altered
(Dyrk1a+/+: 2.7 ± 0.5%; Dyrk1a+/: 3.1 ±
0.8%, n = 4). Notably, the increase in the
EGFRA/EGFRS ratio was found in EGF,
but not in FGF-treated cultures (Fig-
ure 3D), in agreement with the mitogen-
dependent self-renewal defect. Note-
worthy, overexpression of a GFP-Dyrk1A
fusion protein in wild-type cells resulted
in efficient asymmetrical segregation of
both endogenous and ectopically ex-
pressed Dyrk1A and normal EGFRA/
EGFRS ratio (Figures S3C and S3D), a
result compatible with the observed
unaltered self-renewal in Dyrk1A-overex-
pressing cultures.
Notch activity exhibits symmetric or
asymmetric distribution in NSC daugh-
ters and positively correlates with EGFR
expression and self-renewal potential
(Andreu-Agullo´ et al., 2009), and immu-
nostaining for the active Notch intracel-
lular domain (NICD) showed a perfect
match with EGFR and Dyrk1A distribu-
tions in Dyrk1a+/+ cultures (Figure S3E).
Since Dyrk1A heterozygous levels did
not alter the proportion of NICD asym-
metric cell pairs (Figure 3D), it appeared
that normal Dyrk1A levels are required
to sustain bilateral EGFR expression/
maintenance in Notch-symmetric divi-
sions. Therefore, we reasoned that any
manipulation forcing a homogeneous
distribution of Dyrk1A in dividing cells
would produce an increase in EGFR
symmetry that would be less apparent
in heterozygous than in wild-type cul-
tures. Treatment with latrunculin A indeed
resulted in a reduction in the EGFRA/
EGFRS ratio of around 50% in wild-typecultures and of only 15% in Dyrk1a+/ cultures (Figure 3E), in
line with the basal phenotype of the heterozygous condition
and suggesting that EGFR distribution depend on the mitotic
partitioning of Dyrk1A in the dividing NSC. Our data areeptember 3, 2010 ª2010 Elsevier Inc. 371
Figure 4. Dyrk1A Regulates EGFR Degradation in Neural Progenitors
(A) Relative EGFR/b-actin protein levels in WT (+/+) and Dyrk1a+/ (+/) neurospheres.
(B) Representative flow cytometry scan showing cell distribution relative to Alexa 488-conjugated EGF fluorescence in WT and Dyrk1a+/ cells.
(C) Egfr mRNA in (+/+) and (+/) cells and relative Egfr/b-actin levels assessed by qRT-PCR.
(D) Detection of EGFR, Dyrk1A, andGFP and EGFR/b-actin relative values in cells transducedwithDyrk1a (siDyrk1a) or scrambled (siSCRM) siRNA, or expressing
unfused GFP or a GFP-DYRK1A fusion (GFP-hDYRK1A).
(E) EGFR stability time course in cells transduced with shDyrk1A or shSCRM and treated with cycloheximide (CHX) added 48 hr after transfection.
(F) Plot showing the natural log of normalized EGFR (EGFR/vinculin)/normalized EGFR at time zero.
(G) Internalization rate for the Alexa 488-EGF/EGFR complex in c17.2 cells nucleofected with Dyrk1a (siDyrk1a) or scrambled (siSCRM) siRNA.
(H) EGFR immunoblot and relative EGFR/vinculin levels in cells transfected with shDyrk1A or shSCRM and incubated with MG132 or chloroquine (Chloro) in the
presence of CHX.
See also Figure S4.
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dose is the minimum amount of Dyrk1A in a cell needed to
support EGFR levels and, therefore, small stochastic varia-
tions in the homogeneous (symmetric) distribution of heterozy-
gous levels between two daughters leads to maintenance of
EGFR levels in only one of the cells (see proposed model in
Figure S3F).
Dyrk1A Inhibits EGFR Degradation
Because our genetic data suggested that a minimum amount
of Dyrk1A is needed to preserve EGFR levels, we next set out
to get a mechanistic insight into the role of Dyrk1A. In heterozy-
gous cultures, total and surface EGFR protein steady-state
levels were reduced but Egfr mRNA levels were not affected
(Figures 4A–4C), suggesting that Dyrk1A contributes to the372 Cell Stem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier Inmaintenance of normal levels of membrane-bound EGFR by
actions on EGFR posttranscriptional regulation.
As a first step toward the biochemical mechanism, we
analyzed EGFR levels in cells of the c17.2 murine neural stem
cell line (Snyder et al., 1992) with modified amounts of Dyrk1A.
EGFR protein levels were not modified by Dyrk1A overexpres-
sion but became lower whenDyrk1Awas reducedwith a specific
siRNA (Figure 4D). To determine whether the effects were due to
enhanced degradation, the half-life of EGFR was estimated in
cells treated with the protein synthesis inhibitor cycloheximide.
EGFR levels were significantly decreased in Dyrk1A knocked-
down cells during the cycloheximide chase (Figures 4E and 4F),
suggesting that Dyrk1A antagonizes EGFR degradation.
EGFR endocytosis is a major mechanism to control EGF-
dependent signaling and degradation/recycling (Sorkin andc.
Figure 5. EGFR Asymmetric Distribution
Requires Endocytosis-Mediated EGFR
Degradation
(A) Percentage of EGFR and Dyrk1A asymmetric
cell pairs in WT and Dyrk1a+/ cultures with and
without (control) dynasore.
(B) Internalization rate for the Alexa 488-EGF/
EGFR complex in WT and Dyrk1a+/ NSCs.
(C) Percentage of EGFR asymmetry in cell pairs
and number of neurospheres formed by NSCs
nucleofected with siSCRM and siRNAs to interfere
Cbl-b and c-Cbl (the immunoblot illustrates the
efficiency of the siRNA-knockdown).
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EGFR levels through actions on receptor internalization, we
measured ligand/receptor internalization by flow cytometry.
Quantification of the levels of internalized receptor, relative to
initial surface levels, rendered no differences between c17.2
cells transfected with the Dyrk1A siRNA or with a scrambled
siRNA (Figure 4G), an indication that Dyrk1A does not modulate
EGFR internalization rates.
Once internalized, EGFR can either be recycled to the cell
surface or targeted for degradation to late endosomes and
lysosomes (Sorkin and von Zastrow, 2009). Addition of EGF
to serum-starved c17.2 cells resulted in a time-dependent
downregulation of EGFR protein levels, which was sensitive to
lysosomal inhibitor chloroquine at early and late times post-
stimulation and to proteasome inhibitor MG132 at early times
(Figures S4A and S4B), indicating that both degradation path-
ways are active in these cells. The reduction in EGFR levels
observed after EGF stimulation of Dyrk1A-interfered cells was
rescued when the cultures were treated with chloroquine (Fig-
ure 4H), suggesting that normal levels of Dyrk1A antagonize
lysosomal-mediated EGFR degradation. Altogether, our results
indicated that Dyrk1A act as a brake for EGF-induced EGFR
degradation in NPCs.
EGFR Asymmetry/Symmetry Is Dependent
on EGFR Degradation following Internalization
To establish a link between EGFR stability and EGFR distribution
in dividing cells, we focused on two processes associated with
the regulation of EGFR half-life: endocytic internalization of
ligand-receptor complexes and Cbl-dependent degradation.
First, we treated singly dispersed NSCs with dynasore, a com-
pound that hampers endocytosis by selectively inhibiting the
GTPases dynamin 1 and 2 (Macia et al., 2006). Dynasore treat-
ment did not modify the distribution of Dyrk1A but clearly in-
hibited the appearance of EGFRA pairs in both wild-type and
heterozygous cultures (Figure 5A), indicating that endocytosisCell Stem Cell 7, 367–379, Splays a role in the unequal distribution of
EGFR in NSC daughters. Similar to re-
sults in c17.2 cells, no differences were
found between wild-type and Dyrk1a+/
cultures in EGFR internalization rate
(Figure 5B). However, the dynasore treat-
ment restored the proportion of EGFRA in
the heterozygous cultures to wild-typelevels (Figure 5A), an effect compatible with Dyrk1A regulating
EGFR levels and distribution at a step downstream of receptor
internalization.
To provide evidence that asymmetric EGFR distribution in
NSCs requires efficient degradation, we interfered the EGFR-
specific E3 ligase Cbl (c-Cbl and Cbl-b isoforms), a key player
in mediating EGFR downregulation (Levkowitz et al., 1998). Cbl
knockdown decreased the EGFRA/EGFRS cell pair ratio and
increased neurosphere formation when interfered cells were
passaged (Figure 5C). This result is consistent with the proposal
that asymmetric EGFR distribution in NSCs requires efficient
degradation upon ligand-mediated receptor internalization.
EGFR Asymmetry/Symmetry Is Dependent
on Dyrk1A-Dependent Phosphorylation
of EGFR-Signaling Regulator Spry2
To achieve some molecular understanding on how the effects of
Dyrk1A on the regulation of EGFR stability modulate EGFR distri-
bution, we decided to focus on Dyrk1A substrates. The dynasore
results excluded Dyrk1A substrates directly related with endocy-
tosis, such as dynamin or amphiphiysin (Murakami et al., 2009).
However, we have recently identified Spry2 as a Dyrk1A
substrate (Arandaet al., 2008) andconsidered it a likely candidate
to mediate Dyrk1A effects. Sprouty proteins (Spry1 to 4 in
mammals) are modulators of receptor tyrosine kinases-depen-
dent signaling in a cell-context-specific manner. In particular,
Spry2 is able to enhance EGF-dependent signaling by reducing
receptor ubiquitination and the trafficking of EGFR-containing
vesicular bodies from early to late endosomes (Mason et al.,
2006; Kim et al., 2007). Indeed, Spry2 interference in c17.2 cells
led to a reduction in EGFR levels (Figure S5A), an indication
that Spry2, like Dyrk1A, positively contributes to EGFR stabiliza-
tion. Expression data were also compatible with a putative role of
Spry2 in the SEZ; among all four Spry proteins, Spry2 was highly
expressed inSEZ tissue and theonly onedetected in adult neuro-
sphere cultures (Figure 6A). Moreover, GFAP+ cells of the SEZeptember 3, 2010 ª2010 Elsevier Inc. 373
Figure 6. Dyrk1A Effects on EGFR Are Mediated by Phosphorylation of Spry2
(A) Detection of Spry proteins in adult SEZ, ganglionic eminences (GE), or cerebral cortex (Ctx) from E14.5 embryos, and adult neurosphere P4 cultures (NSCs)
by immunoblot.
(B) GFAP and Spry2 in adult SEZ.
(C) Spry2 and Dyrk1A in cell pairs. Topro-3 (B) and DAPI (C) label nuclei.
(D) Spry2 and EGFR in lysates from Dyrk1a+/ cells expressing Flag-Spry2 or the T75A-mutated Spry2 version.
(E) Neurospheres growing from WT and Dyrk1a+/ cells nucleofected with the indicated constructs.
(F and G) Cell pairs with EGFR asymmetry (F) and number of neurospheres (G) in the same cultures as in (E).
(H) EGFR asymmetric cell pairs and sphere number in Dyrk1a+/ cultures expressing HA-DYRK1A, a kinase-deficient version (HA-DYRK1A-KD), or a version
lacking the region that interacts with Spry2 (HA-DYRK1A-DHIS). The dashed line indicates the proportion of asymmetry and sphere numbers in WT cultures.
Scale bars in (B): upper panels, 30 mm; lower panels, 10 mm; (C), 10 mm; (E), 100 mm.
See also Figure S5.
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unlikeDyrk1A or EGFR, Spry2 is not asymmetrically distributed in
NSC daughters (Figures 6B and 6C).
We first interfered endogenous Spry2 in wild-type cells to
explore whether Spry2 could regulate EGFR asymmetry and
observed increased EGFRA/EGFRS cell pair ratios (Figure S5B),
suggestive of a Spry2 involvement in the emergence of biased
EGF signaling. We next tested whether Dyrk1A and Spry2 could
be acting on the same pathway by overexpressing Spry2 in374 Cell Stem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier InDyrk1a heterozygous neurospheres. Exogenously expressed
Spry2 significantly rescued theDyrk1a heterozygous phenotype,
as it resulted in increased EGFR protein levels, reduced EGFRA/
EGFRS cell pair ratio, and higher neurosphere yield (Figures 6D–
6G). In contrast, we were unable to restore wild-type proportions
of EGFRA cell pairs and neurosphere numbers in Dyrk1a+/
cultures by ectopic expression of a Spry2-mutated version in
which the threonine residue that is phosphorylated by Dyrk1A
was substituted by alanine (Spry2-T75A) (Aranda et al., 2008)c.
Figure 7. Dyrk1A Expression Levels Regu-
late EGF-Dependent NSC Fate Decisions
In Vivo
(A) BrdU-LRCs in the SEZ of WT and Dyrk1a+/
saline- and EGF-infused mice.
(B) BrdU-LRC density in the OB granular layer of
WT and Dyrk1a+/mice 1 month after the infusion.
(C) Examples of S100b and BrdU detections in the
striata of EGF- and saline-infused mice 1 month
after EGF infusion. Nuclei are stained with Sytox.
(D) S100b+ BrdU-LRCs in the SEZ of WT and
Dyrk1a+/ mice 1 month after the infusion.
(E) Neurosphere yield fromWT andDyrk1a+/mice
1month after the infusion. Scale bars in (A) and (C),
10 mm.
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Dyrk1A and Neural Stem Cell Self-Renewal(Figures 6D–6G), suggesting that the rescuing effect of Spry2
overexpression on EGFR symmetry requires phosphorylation
by Dyrk1A.
To test this proposal, wild-type neurosphere cultures were
treated with the alkaloid harmine, a specific inhibitor of Dyrk1A
kinase activity, and with norharmane, an analog alkaloid that
does not inhibit Dyrk1A (Laguna et al., 2008). Only harmine treat-
ment reproduced theheterozygousphenotypeas it increased the
proportion of EGFRA cell pairs (norharmane, 30.6 ± 4.4; harmine,
55.4 ± 3.8; n = 3, p < 0.05). Furthermore, EGFRA/EGFRS ratio and
sphere number were restored to normal values when Dyrk1a+/
cellswere nucleofectedwithDyrk1A, but notwith a kinase-defec-
tive version (Dyrk1A-KD) or a mutated Dyrk1A that is catalytically
active but cannot interact with Spry2 (Dyrk1A-DHis; Aranda et al.,
2008) (Figure 6H). These results suggested that Dyrk1A phos-
phorylation of Spry2 is, at least, onemechanismbywhichDyrk1A
antagonizes EGFR degradation.
Dyrk1A Expression Level Regulates EGF-Dependent
NSC-Fate Decisions In Vivo
We next decided to investigate whether NSC self-renewal and
cell-fate decisions in response to EGF were also modified in
Dyrk1a heterozygous tissue. It has reported that hyperprolifera-Cell Stem Cell 7, 367–379, Stion of SEZ progenitors following infusion
of EGF leads to reducedOBneurogenesis
along with increased numbers of termi-
nally differentiated astrocytes in the
SEZ/striatum 1 month after the infusion
(Craig et al., 1996; Kuhn et al., 1997;
Doetsch et al., 2002). We therefore
infused EGF for 7 days into the lateral
ventricle of 2-m (before the heterozygous
phenotype became evident) mice, in-
jected them with BrdU on the last day of
infusion, and one month later, analyzed
BrdU labeling and neurosphere yield.
The relative increase in the number of
BrdU-LRCs cells in the brain of EGF
versus saline-treated animals was similar
between genotypes (around 10-fold) in
wild-type (7014 ± 969 BrdU+ cells in
EGF versus 785 ± 24 in saline, n = 4) and
Dyrk1a+/mice (5109 ± 431 in EGF versus
612 ± 17 in saline, n = 4), indicating that EGFR+ cells can be acti-
vated by acute EGF administration in both genotypes (Figure 7A).
However, neurogenesis/astrogliogenesis and stem cell recovery
1 month after EGF infusion varied markedly between genotypes.
As reported, EGF infusion in wild-types resulted in reduced
numbers of BrdU-LRCs in the OB granular layer and higher
proportions of S100b+ BrdU-LRCs in the SEZ. Interestingly,
both effects were less accentuated in Dyrk1a+/ mice (Figures
7B–7D). Given that S100b-labeling in the SEZ correlates with
loss of neurosphere forming ability in vitro (Raponi et al., 2007),
we next investigated whether the changes induced by EGF infu-
sion correlated with a proliferation-driven exhaustion of stem cell
potential by analyzing neurosphere recovery. EGF infusion
indeed caused a reduction in the recovery of primary neuro-
spheres in wild-type mice; in contrast, neurosphere recovery
was the same from EGF- or saline-infused Dyrk1a+/ mice
(Figure 7E). Together, these data suggested that Dyrk1A is an
in vivo mediator of EGF-induced NSC decisions.
DISCUSSION
Endocytosis-mediated receptor degradation is emerging as a
key regulator of polarized/asymmetric distribution of signalingeptember 3, 2010 ª2010 Elsevier Inc. 375
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during cell division (i.e., for cell fate binary decisions) (Coumail-
leau and Gonza´lez-Gaita´n, 2008). Our data identify Dyrk1A as
a novel regulator of biased signaling in stem cells of the adult
mammalian brain and suggest that intracellular trafficking and
sorting of signaling receptors are also essential processes in
the regulation of stem cell renewal. Dyrk1A protein is actively
distributed during NSC division into its daughters and the in-
herited Dyrk1A acts as an inhibitor of EGFR degradation in
a dosage-sensitive manner, determining the potential for neuro-
sphere formation of each daughter cell. Biochemically, Dyrk1A
antagonizes EGFR degradation after its internalization by, at
least, phosphorylating the modulator of tyrosine kinase receptor
signaling, Spry2.
The mechanism mediating Dyrk1A distribution remains
unknown, although its sensitivity to latrunculin suggests that it
may be cytoskeleton-dependent. Published work in embryonic
NPCs indicates that Dyrk1a mRNA is asymmetrically localized
during mitosis (Ha¨mmerle et al., 2002; 2008), and it is thus
possible that different amounts of protein are translated in
daughter cells upon cell division, similarly to what occurs with
some asymmetric determinants in Drosophila (Knoblich, 2008).
The fact that aDyrk1a cDNA without untranslated regions results
in Dyrk1A asymmetric distribution points to the protein as the
segregation target and suggests alternative possibilities,
including the segregation of Dyrk1A associated to endosomal
compartments, as it happens with the Notch-ligand Delta
(Coumailleau and Gonza´lez-Gaita´n, 2008). Other Dyrk family
members control polarized growth and asymmetric cell division
in yeast and nematodes, acting on the regulation of mitotic
spindle positioning or on degradation-dependent asymmetric
segregation of germ line determinants (Ba¨hler and Nurse,
2001; Pang et al., 2004; Stitzel et al., 2006). Given thatminibrain
has been identified in a RNAi screen for cytokinesis defects and
as a regulator of actin organization (Bettencourt-Dias et al., 2004;
Liu et al., 2009), it remains to be determined whether Dyrk1A can
directly regulate mammalian NSC division mode through addi-
tional actions on the cytoskeleton.
EGF-dependent biased signaling for self-renewal can be
regulated at different levels. For instance, Notch activity is
segregated during NSC division and directly regulates expres-
sion of the Egfr gene (Andreu-Agullo´ et al., 2009). Because
Dyrk1A can antagonize EGFR degradation in cells with high
Notch activity, both mechanisms likely contribute to increase
EGF response. In contrast, increased probability of EGFR degra-
dation versus recycling in the cell with low Notch/low Dyrk1A
could enhance signaling differences between sibling cells.
Although an inhibitory role for Dyrk1A on Notch transcriptional
activity has been reported (Fernandez-Martinez et al., 2009), we
havenot observedchanges inEgfrmRNA levels inDyrk1ahetero-
zygous cells and therefore Dyrk1A activity might not act through
Notch in this cell context. Regulation of Notch activity by Numb
in embryonic progenitors is a classic example of how the asym-
metric partitioning of an intracellular trafficking modulator results
in differential fate in sibling cells and it has been suggested that
Numb terminates Notch-dependent signals by promoting
Notch internalization and degradation through a yet-unknown
mechanism (Knoblich, 2008; Zhong and Chia, 2008). Numb can
also inhibit Shh signaling through Gli1 ubiquitination and376 Cell Stem Cell 7, 367–379, September 3, 2010 ª2010 Elsevier Insubsequent degradation and is involved in EGFR internalization
(Santolini et al., 2000; Di Marcotullio et al., 2006). Given that
Shh, Notch and EGFR positively regulate stem cell self-renewal
(Molofsky et al., 2004; Andreu-Agullo´ et al., 2009), Numb inheri-
tance could be associated with loss of stem potential. In
Drosophila, Numb localizes basally in dividing neuroepithelial
cells, opposite to the localization of the PAR complex (Knoblich,
2008). In neurosphere cultures, NICD, Dyrk1A and EGFR always
segregate with the apical marker aPKCl, suggesting that they
could all be components of a self-renewal promoting machinery.
Our biochemical results indicate that Dyrk1A acts, at least
in part, through binding to and phosphorylation of Spry2. Poten-
tially, this phosphorylation could regulate Spry2 binding to
trafficking regulatory proteins similarly to what has been
described for Spry2 serine residues 112 and 121 (Kim et al.,
2007). We have shown that phosphorylation of Spry2 on Thr75
by Dyrk1A impairs its inhibitory action on FGF-induced
mitogen-activated protein kinase activation (Aranda et al.,
2008) and our present data indicate that the same phosphoryla-
tion event contributes to EGFR accumulation in neurosphere
cells. Although neurosphere cells are responsive to other mito-
gens, such as FGF or PDGF (Molofsky et al., 2004), FGFR or
PDGFR asymmetries are not modified by Dyrk1A genetic reduc-
tion and/or Spry2 overexpression in NSCs (Figure 5SC). Thus the
impact of Spry2 phosphorylation on the responsiveness to
specific mitogens may not equally result in changes in self-
renewal capabilities, in line with the idea that Spry actions are
growth factor- and tissue-specific (Kim and Bar-Sagi, 2004).
Given that a fraction of B astrocytes express high levels of
EGFR and respond to infused EGF and that this mitogen is
essential for the derivation and propagation of adult neurosphere
cultures, it is likely that EGF-dependent signaling contributes to
SEZ homeostasis. In this line, aged mice exhibit reductions in
EGFR and TGFa levels and stem cell potential is reduced in
TGFa hypomorphic mice (Enwere et al., 2004). Higher EGFR
levels correlate with a higher efficacy in neurosphere formation
and NPCs derived from the postnatal and adult SEZ are enriched
in neurosphere forming cells when sorted for high EGFR (Cicco-
lini et al., 2005; Pastrana et al., 2009). Moreover, Notch transcrip-
tional activity correlates with self-renewal and promotes EGFR
expression (Andreu-Agullo´ et al., 2009). Therefore, physical
EGFR asymmetry could result in functional asymmetry and
underlie the reduced longevity of the stem cell pool in Dyrk1a
heterozygous mice. Finally, our observation that EGF-induced
hyperproliferation results in a loss of stem cell potential and of
neurogenesis in wild-type animals, but not in Dyrk1a heterozy-
gous mutants, suggests that a fine balance between symmet-
rical and asymmetrical divisions is important to avoid depletion
of the SEZ stem cell reservoir.
The human DYRK1A gene has been associated with DS
neurological defects (Park et al., 2009). Although transient
ectopic expression of Dyrk1A in NPCs of the developing fetal
cortex results in premature differentiation (Yabut et al., 2010),
we have observed that a moderate increase in Dyrk1A levels
has no apparent effects on adult NSC behavior. Dose-depen-
dent effects of Dyrk1A both in human pathology and rodent
NPCs support that maintenance of a correct Dyrk1A dose is
extremely important to preserve normal neurogenesis, both
during development and in the adult.c.
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Animal Use
Dyrk1a mutant mice (Altafaj et al., 2001; Fotaki et al., 2002) were used in
accordance with institutional guidelines. BrdU (Sigma) was injected intraperi-
toneally (50 mg/g body weight) every 2 hr for a 12 hr period, and mice were
either sacrificed immediately or 4 weeks later (to label LRCs). Infusion
(7 days at a flow rate of 0.5 ml/h; 400 ng EGF/day) and fixation methods with
4% paraformaldehyde have been described (Ferro´n et al., 2007).Neurosphere Cultures, Treatments, and Cell-Pair Analysis
Methods for NSC culture, self-renewal assessment, and cell-pair analysis have
been described (Ferro´n et al., 2007; Andreu-Agullo´ et al., 2009). Isolated cells
were incubated with latrunculin A (50 nM, Sigma), harmine (20 nM, TCI
Europe), or norharmane (20 nM, Sigma) for 90 min, washed, seeded in growth
medium, and fixed 12 hr later. Cells were treated with dynasore (40 nM, Sigma)
for 4 hr at 16 hr after dissociation.Immunostaining
Vibratome sections (30 mm) or cells/neurospheres were immunostained as
described (Ferro´n et al., 2007; see Table S1 for antibody details). Biotinylated
Griffonia simplicifolia IB4 lectin (Sigma) was used at 1:20 and detected with
Cy2-conjugated streptavidin (Jackson Immunochemicals, 1:1000). DAPI
(1 mg/ml), Sytox Green, or Topro-3 (1:1000; Molecular Probes) were used
(5 min) for nuclei counterstaining. Sections were incubated in 2 N HCl for
30min at 37C and neutralized in 0.1 M sodium borate (pH 8.5) before addition
of BrdU antibodies. In some sections, a biotinylated anti-mouse antibody
(1:200; Vector Labs) was used followed by the ABC complex (Vector Labs)
reacted with 0.03% diaminobenzidine (Sigma) and 0.003% hydrogen
peroxide. Immunoperoxidase-reacted sections were used for unbiased
stereological counts of BrdU+ LRCs with the optical dissector method (see
Supplemental Information for details), using a CAST-GRID software package
(Olympus, Denmark) adapted to an Olympus BX51 microscope.Protein and RNA Isolation and Detection
Preparation of cell and tissue extracts, immunoblotting, and RT-PCR condi-
tions have been previously described (Andreu-Agullo´ et al., 2009; see
antibodies in Table S1). Real-time qPCR was performed in a DNA Engine 2
Opticon detection system (Bio-Rad) using SYBR Green I (see primer
sequences in Table S2).Cell Transduction
Neurospheres grown for 2 days were electroporated with DNAs or siRNAs (see
Table S2 for sequences) using a Mouse NSC Nucleofector Kit (Amaxa Biosys-
tems, Germany) or retrovirally infected, dissociated 2 days after transduction,
and seeded at low-density. The retroviral vector pMSCV-puro (Clontech) was
used to generate DYRK1A constructs (wild-type and the kinase inactive
mutant DYRK1A/K179R, DYRK1A-KD); viral stocks were prepared by calcium
phosphate transfection into the Phoenix helper-free cell line (ATCC).
c17.2 cells (generously provided by E. Snyder) were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) plus 10% fetal bovine serum, 5% horse
serum, 1% L-glutamine, and 1% sodium pyruvate. Cells were transfected
with siRNAs (100 nM/35 mm plates) or DNAs (2 mg/35 mm plates) using Lipo-
fectamine 2000 or Lipofectamine/plusReagent in Opti-MEM (Invitrogen),
respectively, and processed after 24 hr (siRNA) or 48 hr (DNA). For the knock-
down experiments, cells were cotransfected with pBABEpuro and selected
with puromycin (1.2 mg/ml, Sigma). For EGFR degradation assays, c17.2 cells
were serum starved for at least 2 hr, and 50 ng/ml EGF was added for the
indicated periods of time. When required, cycloheximide (10 mg/ml), MG132
(10 mM), or chloroquine (200 mM) were added. Plasmids pBSU6-shDYRK1A
and pBSU6-shSCRAMBLE and plasmids to express GFP-tagged DYRK1A,
HA-tagged DYRK1A wild-type, a kinase inactive version and a mutant without
the histidine repeat, and Flag-tagged Spry2 wild-type and T75A mutant
versions have been described (Alvarez et al., 2003; Aranda et al., 2008;
Ortiz-Abalia et al., 2008). A plasmid expressing a shRNA for Spry2 was kindly
provided by D. Bar-Sagi (Kim et al., 2007).CellEGFR Internalization
Cells were EGF-starved for 12 hr and incubated with 25 ng/ml Alexa Fluor
488-conjugated EGF at 4C during 30 min. Low and high EGF populations
were gated on the basis of a 30-fold increase in fluorescence levels with
respect to control cells. Sorting was performed on a MoFlo sorter (Dako),
and at least 200 cells from each population were plated at clonal density
(1 cell/well) in neurosphere medium. For EGFR internalization analysis and
after the incubation with Alexa Fluor 488-conjugated EGF, cells were rinsed
three times with cold PBS, subjected to a cold acid-wash (DMEM, pH 2.2)
for 5 min to remove noninternalized EGF, incubated at 37C for the indicated
times to allow internalization, and fixed. Fluorescence emission was detected
by flow cytometry (MoFlo, Dako) and quantitated using the Sumit 4.0 software
package (Dako).
Statistical Analysis
Analyses of significant differences were performed using the Student’s t test.
When comparisons were performed with relative values (normalized values
and percentages), data were first normalized by using an arcsen transforma-
tion. Each experiment was performed in at least three independent
cultures/animals per genotype and condition, and data are presented as
mean ± SEM. A probability value of less than 5% was considered significant:
***p < 0.001; **p < 0.01; *p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, Supplemental
Experimental Procedures, and two movies and can be found with this article
online at doi:10.1016/j.stem.2010.06.021.
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